9
nov
2021
About us
Biem Pharmaceuticals, with headquarters in Ankara - Turkey, founded in 1989, is a privately held pharmaceutical manufacturer and distribution company focused on offering effective treatment options in Oncology, Hematology, Radiology, Ophthalmology and Transplantology fields.
Specs about this supplier
| Sales markets | Western Europe |
|---|---|
| Affiliated categories: | Drops |Finished Dosage Forms |Injectables More |
Products featured at CPhI Worldwide 2021
❮
❯
-
Conjiten
-
Beastin 100 mg - 25 mg
-
Biemefrin
-
Biemexol 300mg
-
Biemexol 350 mg
-
Biemparin
-
Buslera
-
Emaray 10-15-20 ml
-
Emfer 100 mg/5 ml
-
Enfluat
-
Gadodiem
-
Sedozolam 15 mg/3 ml - 5 mg / 5 ml
-
Mrsacin
-
Ocladra 2 mg/ml
-
Btiray 300
-
Btiray 370
-
Votron
-
Zaridinex
-
Erbinna
-
Trozasin
-
Gloger
-
Calsipar
-
Desibem
-
Kolistate
-
Letroks
-
Biemib
-
Lokaril
-
Pargicyl
BIEM ILAC SAN. ve TIC. A.S.
Event information
CPhI Worldwide 2021
9-11 November 2021 Fiera Milano, Milan, Italy Visit us at stand 3J100Are you a supplier?
Here's what CPhI Online can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation